Pengaruh Penggunaan Alat Kontrasepsi Hormonal Terhadap Kejadian Kanker Payudara di Fasilitas Pelayanan Kesehatan

Authors

  • Putri Sukma Wulandari Universitas Pembangunan Nasional Veteran Jakarta
  • Amelia Jessica Simanjuntak Universitas Pembangunan Nasional Veteran Jakarta
  • Ruth Clara Universitas Pembangunan Nasional Veteran Jakarta
  • Edelwise Lasma Estaurina Napitupulu Universitas Pembangunan Nasional Veteran Jakarta
  • Nayla Kamilia Fithri Universitas Pembangunan Nasional Veteran Jakarta

DOI:

https://doi.org/10.35960/vm.v16i3.1071

Keywords:

Contraception, Hormonal, Breast Cancer

Abstract

Breast cancer is a common cancer that affects women. There are 2.3 million women suffering from breast cancer globally in 2020, with 68,858 cases from Indonesia. Risk factors include prolonged exposure to endogenous estrogens, late menopause, early menarche, first time giving birth at old age, and exogenous hormones. This study aims to determine the role of hormonal contraception against breast cancer. The literature study was made by analyzing 10 articles published between 2018-2023. Literature searches were conducted through electronic databases, namely PubMed, Garuda and Google Scholar. The results of the study stated that users of hormonal contraceptives have a higher risk of developing breast cancer compared to those who do not use hormonal contraceptives.

References

Dorchak, J. A., Maria, S., Guarinoni, J. L., Duensing, A., Somiari, S., Cavanaugh, J., Deyarmin, B., Hu, H., Iida, J., Shriver, C. D., & Witt-Enderby, P. A. (2018). The Impact of Hormonal Contraceptives on Breast Cancer Pathology. Hormones and Cancer, 9(4), 240–253. https://doi.org/10.1007/s12672-018-0332-y

Grandi, G., Sammarini, M., Chiara Del Savio, M., Toss, A., & Facchinetti, F. (2019). Combined hormonal contraceptives in BRCA gene mutation carriers: why not? European Journal of Contraception and Reproductive Health Care, 24(6), 417–419. https://doi.org/10.1080/13625187.2019.1647335

Hasnita, Y. (2020). Prosiding Seminar Kesehatan Perintis E-ISSN : 2622-2256 Tingkat Pendidikan dan Pemakaian Kontrasepsi Hormonal terhadap Kejadian Kanker Payudara Prosiding Seminar Kesehatan Perintis E-ISSN : 2622-2256. 3(1), 139–142.

Hatima, H., Fitrahminarsih, N., & Nirwana. (2022). Faktor Risiko Penggunaan Kontrasepsi Hormonal Terhadap Kejadian Kanker Payudara di RS Bhayangkara Makassar. Riset Rumpun Ilmu Kedokteran, 33(1), 1–12.

Kemenkes RI. (2019). Cancer Burden. In Jakarta: Ministry of Health RI.

Kurniawati, T., Kurniati, L., Elliana, D., & Purwatianingsih, I. (2019). Hubungan Lama Penggunaan Kontrasepsi Hormonal Dan Umur Dengan Kejadian Kanker Payudara Di Rsup Dr. Kariadi Semarang Tahun 2010. Jurnal Ilmu Kebidanan Dan Kesehatan, 10(1), 39–50.

Mardhiah, A., & Anjani, A. D. (2019). Hubungan Penggunaan Kontrasepsi Hormonal Dengan Kejadian Kanker Payudara di RSUD Embung Fatimah Kota Batam Tahun 2017. Jurnal Kebidanan, 09(1), 2–31.

Maulinasari Nasution, W., Aguslina Siregar, F., Magister Kesehatan Masyarakat, A., & Kesehatan Masyarakat Universitas Sumatera Utara, F. (2018). Pengaruh Pemakaian Kontrasepsi Hormonal dan Riwayat Keluarga Terhadap Kejadian Kanker Payudara Di RSUD Dr. Pirngadi Medan Tahun 2017. Jurnal Medika Respati, 13(2), 39–47. http://medika.respati.ac.id/index.php/Medika/article/view/156

Niemeyer Hultstrand, J., Gemzell-Danielsson, K., Kallner, H. K., Lindman, H., Wikman, P., & Sundström-Poromaa, I. (2022). Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15–34 years of age: A nationwide register-based study. The Lancet Regional Health - Europe, 21. https://doi.org/10.1016/j.lanepe.2022.100470

Sulaeman, R., Irwansyah, I., Sukmawati, S., & Masadah, M. (2021). Riwayat Penggunaan Kontrasepsi Hormonal Pada Penderita Kanker Payudara. Jurnal Keperawatan Terpadu (Integrated Nursing Journal), 3(1), 10. https://doi.org/10.32807/jkt.v3i1.96

Vyver, E., & Hwang, L. Y. (2019). A pediatric perspective on hormonal contraception and breast cancer risk: New literature about a recurring question. Paediatrics and Child Health (Canada), 24(4), 224–226. https://doi.org/10.1093/pch/pxy169

White, N. D. (2018). Hormonal Contraception and Breast Cancer Risk. American Journal of Lifestyle Medicine, 12(3), 224–226. https://doi.org/10.1177/1559827618754833

World Health Organization. (2021). Breast Cancer. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/breast-canc

Downloads

Published

2023-07-02

How to Cite

Wulandari, P. S., Simanjuntak, A. J., Clara, R., Napitupulu, E. L. E., & Fithri, N. K. (2023). Pengaruh Penggunaan Alat Kontrasepsi Hormonal Terhadap Kejadian Kanker Payudara di Fasilitas Pelayanan Kesehatan. Viva Medika: Jurnal Kesehatan, Kebidanan Dan Keperawatan, 16(3), 304–309. https://doi.org/10.35960/vm.v16i3.1071

Issue

Vol. 16 No. 3 (2023): VOLUME 16 / Nomor 03 /JULI/ 2023

Section

Articles

License

Submitted paper will be  firstly reviewed by the editors to determine whether the paper meet the edition theme and submission guidelines. Papers which meet the theme and the guidelines will be assigned to selected reviewers for peer-reviews. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan is a double blind peer-reviewed journal which involves  reviewers based on their experties relevant to the topic of the paper. Final decision of paper acceptance is solely decided by the editors according to reviewers' comment.

Plagiarism and self-plagiarism are prohibited. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan uses PlagiarismCheckerX and iThenticate to scan papers for detecting plagiarism. Thus, Appropriate citation and quotation should be used